Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Psychosom Med. 2016 Sep;78(7):776–787. doi: 10.1097/PSY.0000000000000356

Table 3.

Results of subgroup analyses

# of studies in each subgroup Hedges g Effect size (CI) I2 Test of subgroup differences
Chi-squared (df) p
Adjusted analyses
 Adjusted for covariates 30 −0.50 (−0.71, −0.29) 95% 0.00 (1) 0.98
 Did not adjust for covariates 2 −0.51 (−1.06, 0.05) 92%
TL assay
 FISH 3 −0.71 (−1.15, −0.27) 47% 0.91 (2) 0.63
 PCR or Q-PCR 22 −0.46 (−0.71, −0.22) 96%
 Southern Blot 7 −0.52 (−0.87, −0.16) 86%
Psychiatric disorder
 Depressive disorders 11 −0.55 (−0.92, 0.18) 96% 5.48 (4) 0.24
 PTSD 5 −1.27 (−2.12, −0.43) 94%
 Psychotic disorders 6 −0.23 (−0.68, 0.21) 91%
 Anxiety disorders 3 −0.53 (−1.05, −0.01) 97%
 Bipolar disorders 7 −0.26 (−0.75, 0.23) 91%

Note: I2 is the proportion of observed variance that reflects real differences in the effect size for each subgroup.